Crescendo Biologics

Crescendo Biologics

  • Home
  • About Us
    • Overview
    • Investors
    • Strategic Collaborations
  • Our Science
    • Humabody® VH Platform
  • News & Events
    • Press Releases
    • Publications
  • Contact Us
  • LinkedIn
  • Twitter
  • Contact Us
  • Home
  • About Us
    • Overview
    • Investors
    • Strategic Collaborations
  • Our Science
    • Humabody® VH Platform
  • News & Events
    • Press Releases
    • Publications
  • Home
  • About Us
    • Overview
    • Investors
    • Strategic Collaborations
  • Our Science
    • Humabody® VH Platform
  • News & Events
    • Press Releases
    • Publications
  • Contact Us
  • LinkedIn
  • Twitter

41st Annual J.P. Morgan Healthcare Conference

Theodora Harold and Michael Booth attending

Post navigation

Previous PostPrevious FT Global Pharma and Biotech Summit
Next PostNext 43rd Annual Cowen Health Care Conference

Recent Posts

  • Crescendo Biologics enters pre-clinical collaboration with Orano Med to explore Targeted Alpha Therapy
  • Hello world!
  • Clinical Development
  • Crescendo Biologics and Cancer Research UK sign Clinical Development Partnership to develop CB213, a novel bispecific Humabody® therapeutic
  • Chief Medical Officer

Recent Comments

    Archives

    • July 2020
    • May 2020
    • February 2020
    • January 2020
    • October 2019
    • September 2019
    • July 2019

    Categories

    • Front Page
    • In the News
    • PR & News
    • Uncategorised
    • Videos

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Humabody® and Multibody® are registered trademarks of Crescendo Biologics Limited.
    Privacy and Cookies Notice Cambridge Web Design

    We use cookies to give you a better experience on our website. To find out more, and to manage your preferences, please consult our Privacy and Cookie Notice.